Article Details

FibroGen Regains All Rights to Roxadustat from AstraZeneca - GlobeNewswire

Retrieved on: 2024-02-26 21:06:05

Tags for this article:

Click the tags to see associated articles and topics

FibroGen Regains All Rights to Roxadustat from AstraZeneca - GlobeNewswire. View article details on HISWAI: https://www.globenewswire.com/news-release/2024/02/26/2835490/33525/en/FibroGen-Regains-All-Rights-to-Roxadustat-from-AstraZeneca-in-the-United-States-and-Other-AstraZeneca-Territories-Except-China-and-South-Korea.html

Excerpt

The FibroGen – AstraZeneca China Agreement for Roxadustat remains in place FibroGen to explore licensing opportunities for Roxadustat SAN ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up